What is the recommendation for patients with congenital heart disease and ischemic stroke or TIA of presumed cardioembolic origin?
In patients with congenital heart disease and ischemic stroke or TIA of presumed cardioembolic origin, it is recommended to start oral anticoagulant therapy with a VKA (warfarin) for the secondary prevention of stroke or TIA after careful individual assessment of the competing bleeding risks associated with oral anticoagulation.